Key result
Loop diuretics, particularly furosemide, require careful consideration of administration route, dosage thresholds, and patient-specific conditions like chronic kidney disease to maximize efficiency.
A clear understanding of how the mode of delivery impacts bioavailability and required dosage is necessary to maximize the efficiency of furosemide in clinical practice.
Supports individualized furosemide dosing by route and condition; leaves open prospective validation in complex HF and CKD.
Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2015) conducted a review in Edema. Loop diuretics (furosemide) was evaluated. Loop diuretics, particularly furosemide, require careful consideration of administration route, dosage thresholds, and patient-specific conditions like chronic kidney disease to maximize efficiency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: